Tissue engineering as a platform for controlled release of therapeutic agents: Implantation of microencapsulated dopamine producing cells in the brains of rats

Journal of Controlled Release

Volumn 72, Issue 1-3, 2001, Pages 93-100

  Vallbacka, J J ^a   Nobrega, J N ^b   Sefton, M V ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Controlled delivery; Growth factors; Microencapsulation; Parkinson's disease; PC12 cells

Indexed keywords

CYTOKINE; DOPAMINE; GROWTH FACTOR; INSULIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CANNULA; CAUDATE NUCLEUS; CELL FUNCTION; CELL VIABILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CRYOPRESERVATION; DRUG DELIVERY SYSTEM; EXTRACELLULAR MATRIX; GENE THERAPY; IMMUNE SYSTEM; IMPLANTATION; MALE; MAMMAL CELL; MICROENCAPSULATION; NONHUMAN; NUTRIENT; PHENOTYPE; PRIORITY JOURNAL; PUTAMEN; RAT; REPRODUCIBILITY; STEM CELL;

ANIMALS; BRAIN; CELL TRANSPLANTATION; DELAYED-ACTION PREPARATIONS; DOPAMINE; DRUG COMPOUNDING; IMMUNOHISTOCHEMISTRY; MALE; PC12 CELLS; RATS; RATS, SPRAGUE-DAWLEY; TYROSINE 3-MONOOXYGENASE;

EID: 0035858377     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(01)00265-6     Document Type: Article

References (22)

1. Growth factor delivery for tissue engineering
2. Controlled release of endothelial cell growth factor from chitosan-albumin microspheres for localized angiogenesis: In vitro and in vivo studies
3. Release from alginate enhances the biological activity of vascular endothelial growth factor
4. VEGF loaded microspheres injected intramuscularly produce local neovascularization in normal, aged C57BL-6 mice
5. Controlled and modulated release of basic fibroblast growth factor
6. Neovascularization effect of biodegradable gelatin microspheres incorporating basic fibroblast growth factor
7. NGF release from poly(D,Llactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability
8. Sustained release of nerve growth factor from biodegradable polymer microspheres
9. Microencapsulation of genetically engineered fibroblasts secreting nerve growth factor
10. Encapsulated genetically engineered fibroblasts: Release of nerve growth factor and effects in vivo on recovery of cholinergic markers after devascularizing cortical lesions
11. Microencapsulation and transplantation of genetically engineered cells: A new approach to somatic gene therapy
12. Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts - An alternate approach to somatic gene therapy
13. Secretion of recombinant proteins from hydroxyethyl methacrylate-methyl methacrylate capsules
14. Making microencapsulation work: Conformal coating, immobilization gels and in vivo performance
15. Release, storage and uptake of catecholamines by a clonal cell line of nerve growth factor (NGF) responsive pheochromocytoma cells
16. Viability and protein secretion from human hepatoma (HepG2) cells encapsulated in 400-μm polyacrylate microcapsules by submerged nozzle-liquid jet extrusion
17. HEMA-MMA microcapsule implants in hemiparkinsonian rat brain: Biocompatibility assessment using [3H]PK11195 as a marker for gliosis
18. Polymer encapsulated neurotransmitter secreting cells. Potential treatment for Parkinson's disease
19. Agarose enhances the viability of intraperitoneally implanted microencapsulated L929 fibroblasts
20. Dopamine secretion by PC12 cells microencapsulated in a hydroxyethyl methacrylate-methyl methacrylate copolymer